3
Cerberus Capital Management has hired veteran diplomat and corporate lawyer Brian Hook as vice chairman in its internati
Sorry, you need to subscribe to read this article.
If you would like to access this article you must become a
Premium Subscriber.
Premium subscribers receive complete access to our daily breaking news, premium stories, weekly Fundraising & IR Review, Knowledge Bank and LP profiles - all which are accessible via our mobile platform.
Here are the top stocks that are likely to be in focus today:
ICICI Bank: The private sector lender reported a nearly four-fold jump in its March quarter consolidated profit to Rs 4,886 crore as against Rs 1,251 crore in the year-ago period, and spoke of “calibrating” growth in the near term given the second wave of COVID-19 infections.
HCL Technologies: The IT company on Friday posted a 6.1 per cent decline in consolidated net profit in March quarter to Rs 2,962 crore but said it is confident of logging double-digit growth in FY22 revenue on the back of a strong deal pipeline.
Earnings Today: Tech Mahindra, HDFC Life Insurance Company, SBI Card and Castrol India are among 15 companies slated to post their March quarter results today.
The domestic market ended in the red for the week-ended April 23, amid concerns over record jump in Covid cases, increasing lockdown-like restrictions across states and the sombre global market mood. Both Sensex and Nifty declined nearly 2% for the week. Going into the trade this week, analysts expect the nervousness among traders may continue and do not see the volatility easing out. March quarterly earnings, Covid-19 related updates and global trends are among key factors that are likely to guide the market this week, while the monthly expiry of April derivatives contracts will keep the traders on their toes. Besides, movement in rupee, crude and FII flows could also have a bearing on the market trajectory.
Srei Equipment Finance had earlier received expressions of interest from US-based Arena Investors LP and Singapore-based Makara Capital Partners for capital infusion to the tune of $250 million